| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.3 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.3 |